Clinical Trial Update: Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating palbociclib in second-line treatment of advanced sarcomas with CDK4 overexpression; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma
• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Soft-tissue Sarcoma, Osteosarcoma | Phase 2 | Status: UNKNOWN